Your shopping cart is empty!
PDF Preview
Clinical and Laboratory Standards Institute, 06/21/2022
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:21/06/2022
Pages:104
File Size:1 file , 6.8 MB
Note:This product is unavailable in Russia, Belarus
This document provides guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays. This guideline emphasizes particular areas related to assay development and presents a standardized approach for method verification that is specific to mass spectrometry technology.
Performance Standards for Antifungal Disk Diffusion SusceptibilityTesting of Filamentous Fungi; Informational Supplement
$100.00 $200.00
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Proposed Guideline, M51P
$102.00 $205.93
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline--Second Edition, M44A2
Validation of Automated Devices for Immunohematologic Testing Prior to Implementation; Proposed Guideline, ILA33PE
$108.00 $217.13
